These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29079738)

  • 21. Structure-Activity Relationships of Antiplasmodial Pantothenamide Analogues Reveal a New Way by Which Triazoles Mimic Amide Bonds.
    Guan J; Tjhin ET; Howieson VM; Kittikool T; Spry C; Saliba KJ; Auclair K
    ChemMedChem; 2018 Dec; 13(24):2677-2683. PubMed ID: 30370998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fosmetpantotenate (RE-024), a phosphopantothenate replacement therapy for pantothenate kinase-associated neurodegeneration: Mechanism of action and efficacy in nonclinical models.
    Elbaum D; Beconi MG; Monteagudo E; Di Marco A; Quinton MS; Lyons KA; Vaino A; Harper S
    PLoS One; 2018; 13(3):e0192028. PubMed ID: 29522513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of pantothenol against staphylococci possessing a prokaryotic type II pantothenate kinase.
    Chohnan S; Murase M; Kurikawa K; Higashi K; Ogata Y
    Microbes Environ; 2014; 29(2):224-6. PubMed ID: 24759689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The inhibitory action of some antimalarial drugs and related compounds on the hexokinase of yeast and of Plasmodium berghei.
    FRASER DM; KERMACK WO
    Br J Pharmacol Chemother; 1957 Mar; 12(1):16-23. PubMed ID: 13413145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of
    Nurkanto A; Jeelani G; Santos HJ; Rahmawati Y; Mori M; Nakamura Y; Goto K; Saikawa Y; Annoura T; Tozawa Y; Sakura T; Inaoka DK; Shiomi K; Nozaki T
    Front Cell Infect Microbiol; 2021; 11():639065. PubMed ID: 33768012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic Characterization of Plasmodium Putative Pantothenate Kinase Genes Reveals Their Essential Role in Malaria Parasite Transmission to the Mosquito.
    Hart RJ; Cornillot E; Abraham A; Molina E; Nation CS; Ben Mamoun C; Aly AS
    Sci Rep; 2016 Sep; 6():33518. PubMed ID: 27644319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CJ-15,801, a fungal natural product, inhibits the intraerythrocytic stage of Plasmodium falciparum in vitro via an effect on pantothenic acid utilisation.
    Saliba KJ; Kirk K
    Mol Biochem Parasitol; 2005 May; 141(1):129-31. PubMed ID: 15811536
    [No Abstract]   [Full Text] [Related]  

  • 28. The coenzyme A biosynthetic pathway: A new tool for prodrug bioactivation.
    Duncan D; Auclair K
    Arch Biochem Biophys; 2019 Sep; 672():108069. PubMed ID: 31404525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation and characterization of temperature-sensitive pantothenate kinase (coaA) mutants of Escherichia coli.
    Vallari DS; Rock CO
    J Bacteriol; 1987 Dec; 169(12):5795-800. PubMed ID: 2824448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of tumour growth on liver pantothenate, CoA, and fatty acid synthetase activity in the mouse.
    McAllister RA; Fixter LM; Campbell EH
    Br J Cancer; 1988 Jan; 57(1):83-6. PubMed ID: 2831928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basic biochemical investigations as rationale for the design of original antimalarial drugs. An example of phospholipid metabolism.
    Vial HJ; Angelin ML; Elabbadi N; Calas M; Cordinas G; Giral L
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():251-61. PubMed ID: 1343697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploiting the coenzyme A biosynthesis pathway for the identification of new antimalarial agents: the case for pantothenamides.
    Saliba KJ; Spry C
    Biochem Soc Trans; 2014 Aug; 42(4):1087-93. PubMed ID: 25110007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring structural motifs necessary for substrate binding in the active site of Escherichia coli pantothenate kinase.
    Awuah E; Ma E; Hoegl A; Vong K; Habib E; Auclair K
    Bioorg Med Chem; 2014 Jun; 22(12):3083-90. PubMed ID: 24814884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correction of a genetic deficiency in pantothenate kinase 1 using phosphopantothenate replacement therapy.
    Zano SP; Pate C; Frank M; Rock CO; Jackowski S
    Mol Genet Metab; 2015 Dec; 116(4):281-8. PubMed ID: 26549575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved efficacy of doxycycline in liposomes against Plasmodium falciparum in culture and Plasmodium berghei infection in mice.
    Rajendran V; Singh C; Ghosh PC
    Can J Physiol Pharmacol; 2018 Nov; 96(11):1145-1152. PubMed ID: 30075085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unraveling the mode of action of the antimalarial choline analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae.
    Roggero R; Zufferey R; Minca M; Richier E; Calas M; Vial H; Ben Mamoun C
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2816-24. PubMed ID: 15273086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
    Konziase B
    J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
    Bonilla-Ramirez L; Rios A; Quiliano M; Ramirez-Calderon G; Beltrán-Hortelano I; Franetich JF; Corcuera L; Bordessoulles M; Vettorazzi A; López de Cerain A; Aldana I; Mazier D; Pabón A; Galiano S
    Eur J Med Chem; 2018 Oct; 158():68-81. PubMed ID: 30199706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimalarial activity of Floxacrine (HOE 991) I. Studies on blood schizontocidal action of Floxacrine against Plasmodium berghei, P. vinckei and P. cynomolgi.
    Raether W; Fink E
    Ann Trop Med Parasitol; 1979 Dec; 73(6):505-26. PubMed ID: 120142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pantetheinase-resistant pantothenamide with potent, on-target, and selective antiplasmodial activity.
    Macuamule CJ; Tjhin ET; Jana CE; Barnard L; Koekemoer L; de Villiers M; Saliba KJ; Strauss E
    Antimicrob Agents Chemother; 2015; 59(6):3666-8. PubMed ID: 25845876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.